Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities

Bioorg Med Chem Lett. 2023 Feb 1:81:129148. doi: 10.1016/j.bmcl.2023.129148. Epub 2023 Jan 21.

Abstract

Novel indole-piperazine derivatives with a hydroxamic acid moiety were designed and synthesized as selective histone deacetylase 6 (HDAC6) inhibitors. In enzymatic assays, all compounds exhibited nanomolar IC50 values. N-hydroxy-4-((4-(7-methyl-1H-indole-3-carbonyl)piperazin-1-yl)methyl)benzamide, 9c, was the most potent HDAC6 inhibitor (IC50, 13.6 nM). In vitro, 9c induced neurite outgrowth of PC12 cells without producing toxic effects, better than Tubastatin A (Tub A). Additionally, 9c demonstrated blatant neuroprotective activity in PC12 cells against H2O2-induced oxidative damage. In western blot assay, 9c could increase the acetylation of α-tubulin in a dose-dependent manner.

Keywords: HDAC6 inhibitor; Indole-piperazine; Neurite outgrowth; Neuroprotective; Selectivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Histone Deacetylase 6
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases*
  • Hydrogen Peroxide*
  • Hydroxamic Acids / pharmacology
  • Indoles / pharmacology
  • Neuronal Outgrowth
  • Piperazine
  • Rats

Substances

  • Histone Deacetylase 6
  • Histone Deacetylases
  • Piperazine
  • Hydrogen Peroxide
  • Histone Deacetylase Inhibitors
  • Indoles
  • Hydroxamic Acids